Donald Kim Buschmann, M.D. Preventive Medicine - Undersea and Hyperbaric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2424 Wilshire Blvd, Santa Monica, CA 90403 Phone: 310-828-4530 |
Taylor Martin, Preventive Medicine - Public Health & General Preventive Medicine Medicare: Medicare Enrolled Practice Location: 1245 16th St Ste 125, Santa Monica, CA 90404 Phone: 310-315-8900 Fax: 310-315-8902 |
Arash Jacob, D.O. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2128 Pico Blvd, Santa Monica, CA 90405 Phone: 310-664-8818 Fax: 310-664-8878 |
Shirin Poustchi, PHARMD, MD Preventive Medicine - Public Health & General Preventive Medicine Medicare: Medicare Enrolled Practice Location: 2020 Santa Monica Blvd Ste 210, Santa Monica, CA 90404 Phone: 310-458-2381 |
Dr. Denise Magdalena Nunez, M.D. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Medicare Enrolled Practice Location: 1245 16th St Ste 125, Santa Monica, CA 90404 Phone: 310-315-8900 Fax: 310-315-8902 |
Yulsi Lili Fernandez Montero, Medicare: Accepting Medicare Assignments Practice Location: 1920 Colorado Ave, Santa Monica, CA 90404 Phone: 310-319-4700 Fax: 310-453-5106 |
Dr. Deborah Ann Cohen, Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2607 34th St, Santa Monica, CA 90405 Phone: 310-795-3960 |
News Archive
Myriad Genetics, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for BRACAnalysis CDx to be used as the only companion diagnostic in conjunction with AstraZeneca's drug Lynparzaâ„¢ (olaparib).
Can a computer game train your brain to resist sweets? That's the question Drexel University researchers hope to answer with one of two new studies launching this month. They have developed a computer game and smartphone app to help people control unhealthy eating habits and ultimately lose weight.
Hospitals in the Houston area vary in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable.
NYU Medical Center has begun enrolling patients in the first large-scale clinical trial of chelation therapy, a controversial treatment for heart disease widely practiced by complementary and alternative medicine physicians. The new, government-funded nationwide study will determine whether the therapy benefits people with coronary artery disease, the leading cause of death for both men and women in the United States.
› Verified 5 days ago